http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce13303b3e964d3adee99aef61eb3888
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Goldberg |
| name | Richard M. Goldberg Richard M Goldberg |
| given-name | Richard M Richard M. |
| organization-name | b University of North Carolina, Chapel Hill, North Carolina, USA Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital Columbus Ohio; West Virginia University Morgantown West Virginia Cancer and Leukemia Group B Statistical Center; Duke University Medical Center, Durham; Southeast Cancer Control Consortium, Goldsboro; University of North Carolina, Chapel Hill, NC; Brigham and Women's Hospital; Eastern Cooperative Oncology Group; Dana-Farber Cancer Institute, Boston; Massachusetts General, North Shore Cancer Center, Danvers, MA; University of California, San Francisco, San Francisco, CA; National Cancer Institute, Bethesda; National Cancer Institute Expanded Participation Project,... From the Brigham and Women's Hospital; Dana-Farber Cancer Institute, Boston, MA; Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; University of North Carolina at Chapel Hill, Chapel Hill, NC; National Cancer Institute, Bethesda, MD; Ohio State University, Columbus, OH; Memorial Sloan-Kettering Cancer Center, New York, NY; and the University of California at San Francisco, San Francisco, CA. From the Department of Medicine, Division of Hematology/Oncology; and the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Division of Biostatistics, Mayo Clinic, Rochester, MN; Community Clinical Oncology Program, IA Oncology Research Association, Des Moines, IA; Dana-Farber Cancer Institute, Boston, MA; University of Pittsburgh, Pittsburgh, PA; University of Kansas Medical Center, Kansas City, KS; National Cancer Institute of Canada, Saint Catharines, Ontario, Canada From the Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH. The Ohio State University, Columbus, Ohio, USA Alan P. Venook and Robert S. Warren, University of California at San Francisco, San Francisco; Margarita Lopatin, Mark Lee, Kim Clark-Langone, Carl Millward, and Steven Shak, Genomic Health, Redwood City, CA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University, Durham, NC; Paula N. Friedman and Richard L. Schilsky, The University of Chicago, Chicago, IL; Wendy Frankel and Richard M. Goldberg, The Ohio State University, Columbus, OH; Najjia N. Mahmoud, University of... Charles S. Fuchs, Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT; Charles S. Fuchs, Peter C. Enzinger, Jeffrey Meyerhardt, and Robert J. Mayer, Dana-Farber/Partners CancerCare; Harvey J. Mamon and Richard S. Swanson, Brigham and Women’s Hospital, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University; Christopher G. Willett, Duke Cancer Institute, Duke University Medical Center, Durham; Joel E. Tepper, University of North Carolina at Chapel Hill School... From the Cancer Institute of New Jersey, New Brunswick, NJ; Southwest Oncology Group Statistical Center; Puget Sound Oncology Consortium, Seattle, WA; University of Illinois College of Medicine at Peoria, Peoria, IL; University of Pennsylvania Cancer Center, Philadelphia, PA; Dana-Farber Cancer Institute, Boston, MA; University of North Carolina at Chapel Hill, Chapel Hill, NC; The University of Texas Health Science Center, San Antonio, TX; and St Vincent's Comprehensive Cancer Center, New York, NY The James Cancer Hospital and Solove Research Institute, The Ohio State University James Comprehensive Cancer Center, Columbus, OH The Ohio State James Comprehensive Cancer Center and Solove Research Institute, Columbus, Ohio, USA From the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Departments of Medicine and Biostatistics, Duke University, Durham; Department of Medicine, University of North Carolina, Chapel Hill, NC; Department of Medicine, Loyola University, Chicago, IL; Department of Medicine, University of Wisconsin, Madison, WI; Department of Medicine, University of Alberta, Alberta, Canada; and the Dana-Farber Cancer Institute, Boston, MA Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, 460 W 10th Ave., Columbus, OH 43210, USA Department of Radiation Oncology, Division of Hematology and Oncology, Department of Internal Medicine, University of North Carolina School of Medicine and the UNC/Lineberger Comprehensive Cancer Center, Chapel Hill, NC From the Mayo Clinic and Mayo Foundation, Rochester, MN; Allegheny Cancer Center, Pittsburgh, PA; The University of North Carolina at Chapel Hill, Chapel Hill, NC; and Toledo Community Hospital Oncology Program CCOP, Toledo, OH Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus Division of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA Jan Franko and Charles D. Goldman, Mercy Medical Center, Des Moines, IA; Qian Shi, Garth D. Nelson, Henry C. Pitot, Axel Grothey, Steven R. Alberts, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Barbara A. Pockaj, Mayo Clinic, Scottsdale, AZ; and Richard M. Goldberg, University of North Carolina, Chapel Hill, NC. Authors' Affiliations: 1Division of Medical Oncology; 2Alliance Statistics and Data Center, Duke University Medical Center; Durham, North Carolina; 3Section of Hematology/Oncology, University of Chicago Cancer Research Center; Chicago, Illinois; 4Department of Surgery, Brigham and Women's Hospital & Harvard Medical School; Boston, Massachusetts; 5Department of Internal Medicine, Ohio State University; Columbus, Ohio; and 6Division of Medical Oncology, University of California, San Francisco, California Donna Niedzwiecki and Xing Ye, Duke University, Durham; Federico Innocenti, University of North Carolina at Chapel Hill, Chapel Hill, NC; Wendy L. Frankel and Richard M. Goldberg, The Ohio State University, Columbus, OH; Alan P. Venook and Robert S. Warren, University of California-San Francisco, San Francisco, CA; Paula N. Friedman, The University of Chicago, Chicago, IL; Robert J. Mayer, Dana-Farber Cancer Institute; Monica M. Bertagnolli, Brigham and Women’s Hospital, Boston, MA; Thomas Anthony... From the Mayo Clinic and Mayo Foundation, Rochester, MN; British Columbia Cancer Agency, Vancouver, British Columbia; National Cancer Institute of Canada–Clinical Trials Group, Queens University, Kingston, Ontario, Canada; University of Pennsylvania Cancer Center, Philadelphia, PA; Southwest Oncology Group Statistical Center, Seattle, WA; University of Siena, Siena; Ospedali Riuniti, Bergamo, Italy; University of the Mediterranean, Marseilles and Fédération Francophone de Cancérologie Digestive, Dijon,... Department of Internal Medicine and the Comprehensive Cancer Center, Ohio State University, Columbus; Department of Internal Medicine, West Virginia University Cancer Institute, Morgantown, West Virginia From the National Surgical Adjuvant Breast and Bowel Project Operations Office, Pittsburgh; Eastern Cooperative Oncology Group, Philadelphia, PA; Mayo Clinic, Rochester, MN; Cancer and Leukemia Group B, Chicago, IL; Federation Francophone de Cancerologie Digestive, University of the Mediterranean, Marseilles; Groupe Cooperateur Multidisciplinaire en Oncologie, Paris, France; and Southwest Oncology Group Statistical Center, Seattle, WA Section of Gastrointestinal Oncology, Division of Medical Oncology, Department of Medicine, The Ohio State University/Arthur James Cancer Hospital and Richard Solove Research Institute, Columbus, Ohio, USA West Virginia University, Morgantown, Virginia, United States of America. West Virginia University Cancer Institute, Morgantown WV, USA. From the University of North Carolina School of Medicine, Department of Medicine, Division of Hematology-Oncology, Chapel Hill, NC The Ohio State University, Columbus, OH. The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA West Virginia University Cancer Institute, Morgantown Authors' Affiliations: 1Department of Medicine, 2Cancer and Leukemia Group B (CALGB), University of Chicago, Chicago, Illinois; 3Department of Biostatistics and Bioinformatics, and 4Cancer and Leukemia Group B (CALGB) Statistical Center, 5Department of Medicine, Duke University Medical Center, Durham, North Carolina; 6Center for Genomic Medicine, RIKEN, Tokyo, Japan; 7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 8Bioengineering and Therapeutic Sciences, University of California at San Francisco, San Francisco, California; and Departments of 9Pharmacotherapy and Experimental Therapeutics and 10Medicine, University of North Carolina, Chapel Hill, North Carolina 2Institute for Pharmacogenomics and Individualized Therapy;; 3Division of Hematology and Oncology, School of Medicine; and; 4Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina From the National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh; Allegheny General Hospital, Pittsburgh, PA; University of Florida, Gainesville, FL; Helen F. Graham Cancer Center, Newark, DE; University of North Carolina, Chapel Hill; Southeast Cancer Control Consortium – Community Clinical Oncology Program, Goldsboro, NC; Atlanta Cancer Care, Atlanta, GA; Kaiser Permanente, Northern California, Vallejo, CA; Florida... From the Mayo Clinic and Mayo Foundation, Rochester, MN; Allegheny Cancer Center, Pittsburgh, PA; The University of North Carolina at Chapel Hill, Chapel Hill, NC; and the Toledo Community Hospital Oncology Program Community Clinical Oncology Program, Toledo, OH. University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. d The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA; From the Mayo Clinic, Rochester, MN; and University of North Carolina at Chapel Hill, Chapel Hill, NC. From the Division of Medical Oncology and Department of Urology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota; Geisinger Clinical Oncology Program, Danville, Pennsylvania; Iowa Oncology Research Association Community Clinical Oncology Program, Des Moines, Iowa; Sioux Community Cancer Consortium, Sioux Falls; South Dakota Nebraska Oncology Group, Creighton University, University of Nebraska Medical Center and Associates, Omaha, Nebraska From the Radiation Oncology Department, Mayo Clinic Cancer Center, Scottsdale, AZ; Statistics, Mayo Clinic Cancer Center, Rochester, MN; Radiation Oncology, University of North Carolina, Chapel Hill, NC; Radiation Oncology, Kansas City Community Clinical Oncology Program, Kansas City, MO; Medical Oncology, Allegheny General Hospital, NSABP Operations and Biostatistical Center, Pittsburgh, PA; Abramson Cancer Center at the University of Pennsylvania, Philadelphia; and Oncology, Mayo Clinic Cancer Center,... Department of Medicine, School of Medicine and James Cancer Hospital and Soloff Research Center, The Ohio State University, Columbus, Ohio, USA Manish R. Sharma, Elizabeth Gray, and Theodore G. Karrison, University of Chicago, Chicago, IL; Richard M. Goldberg, Ohio State University, Columbus, OH; and Daniel J. Sargent, Mayo Clinic, Rochester, MN. a University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Division of Hematology and Oncology, Chapel Hill, North Carolina, USA From the Dana-Farber Cancer Institute; Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; University of North Carolina, Chapel Hill, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago; Edward Cancer Center, Naperville, IL; Toledo Community Hospital Oncology Program, Toledo, OH; and the Hôpital du... Authors' Affiliations: 1Alliance Statistics and Data Center, 2Mayo Clinic, Rochester, Minnesota; 3Lehigh Valley Hospital, Allentown, Pennsylvania; and 4Ohio State University, Columbus, Ohio From The University of North Carolina at Chapel Hill, Chapel Hill, NC; Mayo Clinic and Mayo Foundation, Rochester, MN; Washington University School of Medicine, St. Louis, MO; Dana-Farber Cancer Institute, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; University of Kansas Medical Center, Kansas City, KS; National Cancer Institute of Canada, St Catharines, Ontario, Canada; and Iowa Oncology Research Association Community Clinical Oncology Program, Des Moines, IA. From the Mayo Clinic, Rochester, MN; Genentech Inc, South San Francisco, CA; Translational Genomics Research Institute, Scottsdale, AZ; Duke University, Durham, NC; and University of North Carolina, Chapel Hill, NC From the Department of Medicine, Division of Hematology-Oncology, University of North Carolina at Chapel Hill; Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and Institut Jules Bordet, Brussels, Belgium Charles D. Blanke, University of British Columbia and British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Brian M. Bot and Daniel J. Sargent, Mayo Clinic, Rochester, MN; David M. Thomas, Peter MacCallum Cancer Centre, Melbourne, Australia; Archie Bleyer, St Charles Medical Center, Bend, OR; Claus-Henning Kohne, Clinic for Oncology and Hematologie, Oldenburg, Germany; Matthew T. Seymour, University of Leeds, Leeds, United Kingdom; Aimery de Gramont, Hospital St Antoine, Paris, France; and... 5WVU Cancer Institute, Morgantown, West Virginia; From the University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill; Sarah Cannon Cancer Research Institute; and the Vanderbilt Ingram Comprehensive Cancer Center, Nashville, TN Department of Medicine, Division of Hematology-Oncology, The University of North Carolina School of Medicine, Chapel Hill, NC 5Mayo Clinic, Rochester, Minnesota; From the Mayo Clinic and Mayo Foundation, Rochester, MN; Geisinger Clinic & Medical Center Community Clinical Oncology Program, Danville, PA; and Saskatchewan Cancer Foundation, Allan Blair Memorial Center, Regina, Saskatchewan, Canada. Authors' Affiliations: 1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Departments of 2Pathology, 3Medicine, and 4Surgery, Brigham and Women's Hospital and Harvard Medical School; 5Departments of Biostatistics and Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 6CALGB Statistical Center, Duke University Medical Center, Durham, North Carolina; 7Memorial Sloan-Kettering Cancer Center, New York, New York; 8Toledo Community Hospital Oncology Program, NCCTG, Toledo, Ohio; 9Hôpital du Sacré-Coeur de Montréal, NCIC, Montreal, Quebec, Canada; 10Loyola University Stritch School of Medicine, SWOG, Maywood, Illinois; 11Northwestern University, Chicago, Illinois; and 12University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Author affiliations appear at the end of this article. West Virginia University Cancer Institute, Morgantown, WV, USA. From the Departments of Medical Genetics, Laboratory Medicine and Pathology, Oncology, Biostatistics, and Clinical Epidemiology, Mayo Foundation, Rochester, MN; Pathology Department, University of Queensland, Queensland; Conjoint Gastroenterology Laboratory, Royal Brisbane Hospital, Brisbane; Department of General Practice and Public Health, University of Melbourne, Victoria, Australia; Departments of Surgery and Pathology, Mt Sinai Hospital, Toronto, Ontario, Canada; and Department of Pathology, Brigham... West Virginia University Cancer Institute Morgantown West Virginia USA Benoist Chibaudel, Christophe Tournigand, and Aimery de Gramont, Hôpital Saint-Antoine, Assistance Publique des Hôpitaux de Paris, Paris; Franck Bonnetain, Centre Georges François Leclerc, Dijon, France; Qian Shi and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Marc Buyse, International Drug Development Institute, Brussels, Belgium; Carmen J. Allegra, University of Florida Shands Cancer Center, Gainesville, FL; and Richard M. Goldberg, North Carolina Cancer Hospital, University of North Carolina Health... g University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA Comprehensive Cancer Center Ohio State University Columbus Ohio Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber... Authors' Affiliations: 1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; 2Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina; 3Dana-Farber Cancer Institute; 4Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts; 5The Ohio State University, Columbus, Ohio; 6National Cancer Institute, Bethesda, Maryland; and 7Memorial Sloan-Kettering Cancer Center, New York, New York Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Columbus Department of Oncology, The Ohio State University Wexner Medical Center, Columbus, OH. From the National Cancer Institute, Bethesda, MD; Mayo Clinic and Mayo Foundation, Rochester, MN; Meritcare Hospital Community Clinical Oncology Program, Fargo, ND; Illinois Oncology Research Association Community Clinical Oncology Program, Peoria, IL; Saskatoon Cancer Centre, Saskatoon; and Allan Blair Cancer Centre, Regina, Saskatchewan, Canada. 6West Virginia University Cancer Institute, Morgantown, West Virginia. University of North Carolina at Chapel Hill Efrat Dotan and Steven J. Cohen, Fox Chase Cancer Center, Philadelphia, PA; Alexander N. Starodub, Indiana University Health Center for Cancer Care, Goshen, IN; Christopher H. Lieu and Wells A. Messersmith, University of Colorado Cancer Center, Aurora, CO; Pamela S. Simpson and Michael J. Guarino, Helen F. Graham Cancer Center & Research Institute, Newark, DE; John L. Marshall, Ruesch Center for the Cure of GI Cancers, Georgetown University Hospital, Washington, DC; Richard M. Goldberg, The Ohio State... From the North Central Cancer Treatment Group; Mayo Clinic, Rochester, MN; Radiation Therapy Oncology Group, Philadelphia, PA; Missouri Valley Cancer Consortium, Omaha, NE; Southwest Oncology Group, San Antonio, TX; National Cancer Institute of Canada—Clinical Trials Group, Kingston, Ontario, Canada; Eastern Cooperative Oncology Group, Boston, MA; Cancer and Leukemia Group B, Chicago, IL From the Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC; Divisions of Biostatistics and Medical Oncology, Mayo Clinic, Rochester, MN; Iowa Oncology Research Association Community Clinical Oncology Program, Des Moines, IA; Department of Oncology, Dana-Farber Cancer Center Institute, Boston, MA; Division of Medical Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City,... From the Department of Medicine, Division of Hematology/Oncology; the Lineberger Comprehensive Cancer Center; and the University of North Carolina Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC; and Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN. Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC. Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA From the Mayo Clinic, Rochester, MN; University of North Carolina, Chapel Hill, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; Klinikum Oldenburg, Oldenburg; Klinikum Bremen, Bremen, Germany; Cancer Research Center UK Clinical Centre, Leeds; Medical Research Council, London, United Kingdom; Hopital Saint Antoine, Paris; Hopital Ambroise Pare, Boulogne; and Center R. Gauducheau, St Herblain, France. From the Mayo Clinic and Mayo Foundation, Rochester, and Duluth Community Clinical Oncology Program (CCOP), Duluth, MN; Illinois Oncology Research Association CCOP, Peoria, IL; Scottsdale CCOP, Scottsdale, AZ; Missouri Valley Cancer Consortium, Omaha, NE; Saskatoon Cancer Centre, Saskatoon, and Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Sioux Community Cancer Consortium, Sioux Falls, SD; and Toledo Community Hospital Oncology Program CCOP, Toledo, OH. Donna Niedzwiecki, Duke University, Durham, NC; Wendy L. Frankel, The Ohio State University, Columbus, OH; Alan P. Venook, University of California, San Francisco, San Francisco, CA; Xing Ye, Duke University, Durham, NC; Paula N. Friedman, Northwestern University, Chicago, IL; Richard M. Goldberg, The Ohio State University, Columbus, OH; Robert J. Mayer, Dana-Farber Cancer Institute, Boston, MA; Thomas A. Colacchio, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Jude Marie Mulligan, Timothy S. Davison,... a Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA West Virginia University Cancer Institute, Mary Babb Randolph Cancer Center, and Department of Medicine, West Virginia University, Morgantown, West Virginia, USA From the University of North Carolina, Chapel Hill, NC; Sanofi-Aventis; Hôpital Saint Antoine; Hôpital Tenon, Paris, France; Institut J Bordet, Bruxelles, Belgium; Vanderbilt Hospital, Nashville, TN; and the Mayo Clinic, Rochester, MN. Professor of Medicine and Director West Virginia University Cancer Institute Morgantown WV Authors' Affiliation: Mayo Clinic and Mayo College of Medicine, Rochester, Minnesota Division of Hematology/Oncology, University of North Carolina, Chapell Hill, NC, USA. Mayo Clinic Jacksonville, Jacksonville, FL; Mayo Clinic Rochester, Rochester, MN; Carle Cancer Center Community Clinical Oncology Program, Urbana, IL; Southwest Oncology Group Operations Office, San Antonio, TX; Eastern Cooperative Oncology Group Data Management Office, Brookline, MA; Missouri Valley Cancer Consortium, Omaha, NE; Mayo Clinic Arizona, Scottsdale, AZ; and University of North Carolina at Chapel Hill, Chapel Hill, NC. From the Swim Across America Laboratory (D.T.L., J.N.U., B.R.B., L.A.D.), Sidney Kimmel Comprehensive Cancer Center (D.T.L., J.N.U., H.W., H.K., A.D.E., A.D.S., B.S.L., N.S.A., D.L., B.B., R.C.D., D.M.P., N.P., K.W.K., S.Z., B.V., L.A.D.), Ludwig Center and Howard Hughes Medical Institute (B.R.B., A.D.S., N.P., K.W.K., S.Z., B.V., L.A.D.), and the Departments of Radiology (A.Z.) and Pathology (F.B., T.H., R.H.H., L.D.W., N.C., T.C.C., J.M.T., R.A.A., J.R.E.), Johns Hopkins University School of Medicine,... Mayo Clinic, USA. West Virginia University Cancer Institute and the Mary Babb Randolph Cancer Center Morgantown West Virginia USA Authors' Affiliations: 1Department of Mathematics, Vassar College, Poughkeepsie, New York; Departments of 2Health Sciences Research and 3Medical Oncology, Mayo Clinic, Rochester, Minnesota; 4Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York; and 5Division of Hematology and Oncology, University of North Carolina, Chapel Hill, North Carolina Division of Medical Oncology, Ohio State University, Columbus, Ohio. From the North Central Cancer Treatment Group, Divisions of Hematology/Oncology and Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC; North Central Cancer Treatment Group, Division of Biostatistics, Mayo Clinic, Rochester, MN; North Central Cancer Treatment Group, Iowa Oncology Research Association Community Clinical Oncology Program, Des Moines, IA; Cancer and Acute Leukemia Group B, Department of Oncology, Dana-Farber Cancer Institute, Boston, MA; Eastern Cooperative... The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210;, , Associate Director for Clinical Research, Lineberger Comprehensive Cancer Center, Chief of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC. Division of Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210-1280, USA Authors' Affiliation: University of North Carolina Schools of Pharmacy and Medicine, Lineberger Comprehensive Cancer Center, and University of North Carolina Institute for Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina West Virginia University Cancer Institute, Morgantown, WV, USA Department of Medicine, James Cancer Center The Ohio State University Columbus Ohio Qian Shi, Axel Grothey, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Aimery de Gramont and Benoist Chibaudel, Hospital Saint Antoine; Christophe Tournigand, Université Paris Est Créteil, Paris; Jean-Yves Douillard, Institute of Cancer Research in Western, St Herblain, France; John Zalcberg, Monash University; Niall C. Tebbutt, Austin Health, Melbourne, Victoria, Australia; Hans-Joachim Schmoll, Martin-Luther University, Halle; Rainer Porschen, Klinikum Bremen-Ost, Bremen; Volker Heinemann,... From the Department of OncologyMayo Clinic and Foundation, Rochester, MN, and Department of Pharmaceutics and Pharmacodynamics, College of Pharmacy, University of Illinois, Chicago, IL. Mary Babb Randolph Cancer Center, West Virginia University Cancer Institute, Morgantown, WV, USA 12The West Virginia University Mary Randolph Babb Cancer Center, Morgantown, West Virginia. Division of Hematology and Oncology, University of North Carolina at Chapel Hill and Lineberger Comprehensive Cancer Center, Chapel Hill, NC. 4West Virginia University Cancer Institute, Morgantown, West Virginia. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC. Department of Medicine, Morgantown, West Virginia, USA; West Virginia University Cancer Institute, Morgantown, West Virginia, USA; Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia, USA Peter C. Enzinger and Robert J. Mayer, Dana-Farber Cancer Institute, Harvard Medical School, and Alliance for Clinical Trials in Oncology, Boston, MA; Barbara Ann Burtness and Steven J. Cohen, Fox Chase Cancer Center; Barbara Ann Burtness, Steven J. Cohen, and Al Bowen Benson III, Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group, Philadelphia, PA; Donna Niedzwiecki, Xing Ye, and Kathe Douglas, Alliance Statistics and Data Center, Duke University,... From the National Surgical Adjuvant Breast and Bowel Project; Graduate School of Public Health, University of Pittsburgh; and Allegheny General Hospital, Pittsburgh, PA; University of Florida, Gainesville; and Florida Cancer Specialists–Sarasota, FL; Helen F. Graham Cancer Center at Christiana Care, Newark, DE; Southeast Cancer Control Consortium–Community Clinical Oncology Program (CCOP), Goldsboro, NC; Atlanta Cancer Care Regional CCOP, Atlanta, GA; Kaiser Permanente Northern California, Vallejo, CA;... From the Divisions of Medical Oncology and Biostatistics, Mayo Clinic, Rochester, MN; Division of Oncology, University of North Carolina, Chapel Hill, NC; and Department of Hematology/Oncology, University of Halle, Halle, Germany From the University of Chicago Cancer Research Center and Northwestern University Feinberg School of Medicine, Chicago, IL; Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; University of North Carolina at Chapel Hill, Chapel Hill, NC; Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Delaware Christiana Care Community Clinical Oncology Program and Helen F. Graham Cancer Center, Wilmington, DE; and Washington University... Division of Medical Oncology, Ohio State University, Columbus From Hopital Saint Antoine; Group Hospitalier Pitie-Salpetriere, Paris, France; International Drug Development Institute, Louvain-la-Neuve, Belgium; National Cancer Institute of Canada Clinical Trials Group, Queens University, Kingston, Ontario; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Divisions of Medical Oncology and Biomedical Statistics and Informatics, Mayo Clinic, Rochester; University of Minnesota, Minneapolis, MN; National Surgical Adjuvant Breast and Bowel Project ... Medical Oncology West Virginia University Cancer Institute, Morgantown, WV From the Dana-Farber Cancer Institute, Boston, MA; University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA; Cancer and Leukemia Group B Statistical Center, Duke University, Durham; University of North Carolina Comprehensive Cancer Center, Chapel Hill, NC; University of Chicago Medical Center, Chicago, IL; Mount Sinai Comprehensive Cancer Center, Miami, FL; and Martha Jefferson Hospital, Charlottesville, VA. The Ohio State University Comprehensive Cancer Center, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus UNC Institute for Pharmacogenomics & Individualized Therapy, University of North Carolina at Chapel Hill, 1094 Genetic Medicine Building, CB 7361, 120 Mason Farm Road, Chapel Hill, NC 27599-7361, USA. From the Divisions of Medical Oncology and Biostatistics, Mayo Clinic, Rochester, and The Duluth Clinic, Ltd, Duluth, MN; and Iowa Oncology Research Association, Des Moines, IA. From the Mayo Clinic and Mayo Foundation, Rochester, MN; Toledo Community Hospital Oncology Program Community Clinical Oncology Program (CCOP), Toledo, OH; Wichita CCOP, Wichita, KS; Meritcare Hospital CCOP, Fargo, ND; Carle Cancer Center CCOP, Urbana, IL; and Geisinger Medical Center, Danville, PA. Monica M. Bertagnolli and Mark Redston, Brigham and Women's Hospital; Monica M. Bertagnolli and Robert J. Mayer, Dana-Farber Cancer Institute, Boston, MA; Donna Niedzwiecki, Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; Richard M. Goldberg, University of North Carolina at Chapel Hill, Chapel Hill, NC; Carolyn C. Compton, National Cancer Institute, Bethesda, MD; Thomas A. Colacchio, Dartmouth Hitchcock Medical Center, Hanover, NH; Leonard B. Saltz, Memorial Sloan... c University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA From the Department of OncologyMayo Clinic and Foundation, Rochester, MN. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27599, USA. goldberg@med.unc.edu Frank A. Sinicrope, Michelle R. Mahoney, Thomas C. Smyrk, Stephen N. Thibodeau, Garth D. Nelson, Daniel J. Sargent, and Steven R. Alberts, Mayo Clinic, Mayo Cancer Center and the North Central Cancer Treatment Group, Rochester, MN; Robert S. Warren, University of California San Francisco, San Francisco, CA; Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA; and Richard M. Goldberg, The Ohio State University Comprehensive Cancer Center, Columbus, OH. From the Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA; North Central Cancer Treatment Group; Mayo Clinic, Rochester, MN; University of North Carolina, Chapel Hill, NC; Medical University of South Carolina, Charleston, SC; and the Jewish General Hospital, McGill University, Montreal, Quebec, Canada. From the North Central Cancer Treatment Group, Mayo Clinic, Rochester, MN; National Surgical Adjuvant Breast and Bowel Project Statistical Center and Operations Office, Pittsburgh; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; QUASAR Collaborative Group, Birmingham and Oxford, United Kingdom; Southwest Oncology Group Statistical Center, Seattle, WA; International Drug Development Institute, Brussels, Belgium; Ospedali Riuniti, Bergamo; University of Siena, Siena, Italy; University... From the Fox Chase Cancer Center, Philadelphia, PA; Cancer and Leukemia Group B Statistical Center, Duke University Medical Center; and University of North Carolina at Chapel Hill, Durham; and Wake Forest University, Winston-Salem, NC; Doctors Medical Center, San Pablo, CA; Dartmouth-Hitchcock Medical Center, Lebanon, NH; Southern Nevada Cancer Research Foundation Community Clinical Oncology Program, Las Vegas, NV; and Dana Farber Cancer Institute, Boston, MA The Ohio State University Medical Center, Columbus, OH, USA Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA The Ohio State University James Comprehensive Cancer Center, Columbus, OH Lindsay A. Renfro, Axel Grothey, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Richard M. Goldberg, The Ohio State University, Columbus, OH; Alberto Sobrero, Ospedale San Martino, Genoa; Alfredo Falcone, University Hospital of Pisa, Pisa, Italy; Richard Adams, Cardiff University, Cardiff; Matthew T. Seymour, St James’s Hospital and University of Leeds, Leeds, United Kingdom; Volker Heinemann, University of Munich, Munich; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle; Rainer Porschen,... 5University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, 519C James Cancer Hospital, 300 West 10th Avenue, Columbus, OH 43210, USA West Virginia University Cancer Institute, Morgantown, West Virginia, USA 7University of North Carolina-Chapel Hill, Chapel Hill, North Carolina; and Division of Medical Oncology Department of Internal Medicine The Ohio State University Comprehensive Cancer Center Columbus OH University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA From the Division of Medical Oncology, Division of Oncology Research, Biostatistics, and Department of Neurology, Mayo Clinic, Rochester, MN. From the Mayo Clinic and Foundation, Department of Oncology, Rochester, MN; University of Alabama in Birmingham, Birmingham, AL; and Glaxo Wellcome, Inc, Research Triangle Park, NC. Departments of Hematology/Oncology & Radiation Oncology, University of North Carolina School of Medicine, NC, USA; Physicians Office Building, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC 27599, USA. 3009 Old Clinic Building, CB#7305, Chapel Hill, NC 27599-7305, USA 1University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Lindsay A. Renfro and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Fotios Loupakis and Alfredo Falcone, Azienda Ospedaliero-Universitaria Pisana and Università di Pisa, Pisa, Italy; Richard Adams, Cardiff University, Cardiff; Matthew T. Seymour, St James's Hospital and University of Leeds, Leeds, United Kingdom; Volker Heinemann, University of Munich, Munich; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle; Rainer Porschen, Klinikum Bremen-Ost Klinik für Innere Medizin, Bremen; Carsten... Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC University of North Carolina, Chapel Hill, Chapel Hill, NC, USA. |
Incoming Links
Total number of triples: 487.